Fabián Herrera

959 total citations
26 papers, 385 citations indexed

About

Fabián Herrera is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Fabián Herrera has authored 26 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in Fabián Herrera's work include Neutropenia and Cancer Infections (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Fabián Herrera is often cited by papers focused on Neutropenia and Cancer Infections (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Bacterial Identification and Susceptibility Testing (3 papers). Fabián Herrera collaborates with scholars based in Argentina, United States and United Kingdom. Fabián Herrera's co-authors include Anabel Gómez-Ríos, Siham Tabik, José Luis Martín Rodríguez, David Charte, Iván Sevillano-García, Julián Luengo, Juan Luis Suárez, Emilio Guirado, Pablo Bonvehí and Analía Mykietiuk and has published in prestigious journals such as European Journal of Cancer, Radiotherapy and Oncology and Digestive Diseases and Sciences.

In The Last Decade

Fabián Herrera

24 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fabián Herrera Argentina 7 228 148 62 46 45 26 385
Adela Sulejmani Italy 6 40 0.2× 42 0.3× 51 0.8× 27 0.6× 33 0.7× 9 273
Shiraz Gefen-Halevi Israel 8 115 0.5× 80 0.5× 54 0.9× 27 0.6× 132 2.9× 15 446
Shannan N. Rich United States 9 25 0.1× 98 0.7× 61 1.0× 36 0.8× 60 1.3× 28 388
Ștefan Udriștoiu Romania 8 68 0.3× 57 0.4× 48 0.8× 17 0.4× 8 0.2× 32 254
Hana L. Haver United States 6 156 0.7× 115 0.8× 97 1.6× 214 4.7× 108 2.4× 12 386
Marianne Breuninger Germany 7 141 0.6× 58 0.4× 66 1.1× 16 0.3× 94 2.1× 10 388
Loes Braun Netherlands 8 229 1.0× 193 1.3× 58 0.9× 139 3.0× 67 1.5× 21 645
Sushil Kumar India 9 43 0.2× 35 0.2× 60 1.0× 7 0.2× 45 1.0× 65 486
Pragnya Maduskar Netherlands 11 465 2.0× 162 1.1× 93 1.5× 46 1.0× 164 3.6× 19 618

Countries citing papers authored by Fabián Herrera

Since Specialization
Citations

This map shows the geographic impact of Fabián Herrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabián Herrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabián Herrera more than expected).

Fields of papers citing papers by Fabián Herrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fabián Herrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabián Herrera. The network helps show where Fabián Herrera may publish in the future.

Co-authorship network of co-authors of Fabián Herrera

This figure shows the co-authorship network connecting the top 25 collaborators of Fabián Herrera. A scholar is included among the top collaborators of Fabián Herrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabián Herrera. Fabián Herrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Herrera, Fabián. (2024). LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM?. Mediterranean Journal of Hematology and Infectious Diseases. 16(1). e2024039–e2024039. 3 indexed citations
2.
3.
Rodríguez, Pablo, et al.. (2020). CLINICAL USEFULNESS OF BROCHOALVEOLAR LAVAGE IN THE MANAGEMENT OF PULMONARY INFILTRATES IN ADULTS WITH HAEMATOLOGICAL MALIGNANCIES AND STEM CELL TRANSPLANTATION. Mediterranean Journal of Hematology and Infectious Diseases. 12(1). e2020025–e2020025. 4 indexed citations
4.
Tabik, Siham, Anabel Gómez-Ríos, José Luis Martín Rodríguez, et al.. (2020). COVIDGR Dataset and COVID-SDNet Methodology for Predicting COVID-19 Based on Chest X-Ray Images. IEEE Journal of Biomedical and Health Informatics. 24(12). 3595–3605. 244 indexed citations
5.
Herrera, Fabián, et al.. (2019). Proposal of a clinical score to stratify the risk of multidrug-resistant gram-negative rods bacteremia in cancer patients. The Brazilian Journal of Infectious Diseases. 24(1). 34–43. 3 indexed citations
6.
Herrera, Fabián, et al.. (2018). Prognostic factors for 7-day and 30-day mortality during gram-negative bacteremia episodes in cancer and hematopoietic stem cell transplant patients. International Journal of Infectious Diseases. 73. 3–3. 3 indexed citations
7.
Herrera, Fabián, Valerio Vagnoni, Avital Harari, et al.. (2018). EP-1577: Prostate cancer SBRT dose escalation to the dominant nodule/s: Phase I and immunological effects. Radiotherapy and Oncology. 127. S849–S849. 1 indexed citations
8.
Bonvehí, Pablo, et al.. (2017). [Etiology and antimicrobial resistance of uncomplicated urinary tract infections].. PubMed. 77(4). 304–308. 5 indexed citations
9.
Caeiro, Juan Pablo, et al.. (2017). Multidrug-resistant Gram-negative Bacteremia in Cancer Patients: Development of a Clinical Score for Risk Assessment. Open Forum Infectious Diseases. 4(suppl_1). S710–S710. 1 indexed citations
10.
Caeiro, Juan Pablo, et al.. (2016). Bacteremia in Cancer Patients. Comparison between Solid and Hematological Tumors and Impact on 30-day Mortality. Open Forum Infectious Diseases. 3(suppl_1). 2 indexed citations
11.
Relloso, Silvia, et al.. (2013). Saksenaea erythrospora infection following a serious sailing accident. Journal of Medical Microbiology. 63(2). 317–321. 16 indexed citations
12.
Valério, Massimo, et al.. (2011). [Active surveillance in prostate cancer].. PubMed. 7(320). 2388–91. 4 indexed citations
13.
Stryjewski, Martín E., Fabián Herrera, Marcela Echavarría, et al.. (2010). Healthcare personnel infected with novel influenza A H1N1 virus in university hospitals in Buenos Aires, Argentina. Scandinavian Journal of Infectious Diseases. 43(1). 70–74. 4 indexed citations
14.
Mykietiuk, Analía, et al.. (2009). Nephrotoxicity associated with the use of intravenous colistin. Scandinavian Journal of Infectious Diseases. 41(10). 767–769. 22 indexed citations
15.
Herrera, Fabián, Sébastien Duband, Martial Koenig, & P. Cathébras. (2007). Une hypergammaglobulinémie considérable. La Revue de Médecine Interne. 29(5). 408–409.
16.
Herrera, Fabián, et al.. (2005). Adherence to an occupational blood borne pathogens exposure management program among healthcare workers and other groups at risk in Argentina. The Brazilian Journal of Infectious Diseases. 9(6). 454–458. 15 indexed citations
17.
Scapellato, Pablo, et al.. (2004). Osteonecrosis en pacientes infectados por HIV. Medicina-buenos Aires. 64(4). 325–331. 3 indexed citations
18.
Ridruejo, Ezequiel, et al.. (2004). CASE REPORT: Severe Cholestatic Hepatitis as the First Symptom of Secondary Syphilis. Digestive Diseases and Sciences. 49(9). 1401–1404. 17 indexed citations
19.
Echavarría, Marcela, et al.. (2003). Cyclic recovery of adenovirus in a stem cell transplant recipient: an inverse association with graft-versus-host disease. Bone Marrow Transplantation. 31(4). 301–303. 6 indexed citations
20.
Mykietiuk, Analía, et al.. (2001). Clinical Ergotism Induced by Ritonavir. Scandinavian Journal of Infectious Diseases. 33(10). 788–789. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adela Sulejmani Breakdown of academic impact, for papers by Shiraz Gefen-Halevi Breakdown of academic impact, for papers by Shannan N. Rich Breakdown of academic impact, for papers by Ștefan Udriștoiu Breakdown of academic impact, for papers by Hana L. Haver Breakdown of academic impact, for papers by Marianne Breuninger Breakdown of academic impact, for papers by Loes Braun Breakdown of academic impact, for papers by Sushil Kumar Breakdown of academic impact, for papers by Pragnya Maduskar
Rankless by CCL
2026